MENU
PGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Precigen (PGEN) Ownership - Who owns Precigen?

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms... Show more

Profile

Industry
N/A
Address
20374 Seneca Meadows Parkway
Phone
+1 301 556-9900
Employees
47
Web
http://www.precigen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.58B
P/E Ratio
N/A
Total Cash
121.14M
Projected Growth
N/A
Total Debt
98.19M
Revenue
6.31M
Risk (Beta)
0.86
Dividend Yield
N/A
Total Cash/Share
0.34
Total Debt/Equity
N/A
Revenue/Share
0.10 USD as % of share price
View a ticker or compare two or three
PGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in the research and development of synthetic biology technologies.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
20374 Seneca Meadows Parkway
Phone
+1 301 556-9900
Employees
47
Web
http://www.precigen.com